Mitigation of gastrointestinal graft-<i>versus</i>-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
Saurabh Chhabra, Anikó Szabó, Annelie Clurman, Katelynn McShane, Nicholas R. Waters, Daniel Eastwood, Lisa Samanas, Teng Fei, Gabriel K. Armijo, Sameen Abedin, Walter Longo, Parameswaran Hari, Mehdi Hamadani, Nirav N. Shah, Lyndsey Runaas, James H. Jerkins, Marcel R.M. van den Brink, Jonathan U. Peled, William R. Drobyski
Abstract
Not available.
Topics & Concepts
TocilizumabMedicineDiversity (politics)Internal medicineGastroenterologyBiologyDiseasePolitical scienceLawGut microbiota and healthRenal Transplantation Outcomes and TreatmentsClinical Nutrition and Gastroenterology